These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 31980121)
1. Benefits and Challenges of Diabetes Technology Use in Older Adults. Toschi E; Munshi MN Endocrinol Metab Clin North Am; 2020 Mar; 49(1):57-67. PubMed ID: 31980121 [TBL] [Abstract][Full Text] [Related]
2. Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes. Kravarusic J; Aleppo G Endocrinol Metab Clin North Am; 2020 Mar; 49(1):37-55. PubMed ID: 31980120 [TBL] [Abstract][Full Text] [Related]
3. Automated Insulin Delivery in Children with Type 1 Diabetes. Cengiz E Endocrinol Metab Clin North Am; 2020 Mar; 49(1):157-166. PubMed ID: 31980115 [TBL] [Abstract][Full Text] [Related]
4. Evolution of Diabetes Technology. Dovc K; Battelino T Endocrinol Metab Clin North Am; 2020 Mar; 49(1):1-18. PubMed ID: 31980111 [TBL] [Abstract][Full Text] [Related]
5. Use of Diabetes Technology in Children: Role of Structured Education for Young People with Diabetes and Families. Desrochers HR; Schultz AT; Laffel LM Endocrinol Metab Clin North Am; 2020 Mar; 49(1):19-35. PubMed ID: 31980118 [TBL] [Abstract][Full Text] [Related]
6. Integration of Diabetes Technology in Clinical Practice. Peters AL Endocrinol Metab Clin North Am; 2020 Mar; 49(1):69-77. PubMed ID: 31980122 [TBL] [Abstract][Full Text] [Related]
7. Recent advances in management of type 1 diabetes. Pyrlis F; Brown F; Ekinci EI Aust J Gen Pract; 2019 May; 48(5):256-261. PubMed ID: 31129934 [TBL] [Abstract][Full Text] [Related]
8. New closed-loop insulin systems. Boughton CK; Hovorka R Diabetologia; 2021 May; 64(5):1007-1015. PubMed ID: 33550442 [TBL] [Abstract][Full Text] [Related]
9. Type 1 diabetes technology: advances and challenges. The Lancet Diabetes Endocrinology Lancet Diabetes Endocrinol; 2019 Sep; 7(9):657. PubMed ID: 31439271 [No Abstract] [Full Text] [Related]
10. Glycemic Status Assessment by the Latest Glucose Monitoring Technologies. Malandrucco I; Russo B; Picconi F; Menduni M; Frontoni S Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153229 [TBL] [Abstract][Full Text] [Related]
11. Diabetes Technology and Exercise. Riddell MC; Pooni R; Fontana FY; Scott SN Endocrinol Metab Clin North Am; 2020 Mar; 49(1):109-125. PubMed ID: 31980112 [TBL] [Abstract][Full Text] [Related]
12. Transforming type 1 diabetes: the next wave of innovation. Drucker DJ Diabetologia; 2021 May; 64(5):1059-1065. PubMed ID: 33550440 [TBL] [Abstract][Full Text] [Related]
13. 'Smart' insulin-delivery technologies and intrinsic glucose-responsive insulin analogues. Jarosinski MA; Dhayalan B; Rege N; Chatterjee D; Weiss MA Diabetologia; 2021 May; 64(5):1016-1029. PubMed ID: 33710398 [TBL] [Abstract][Full Text] [Related]
14. Technology in Diabetes: The Future Is Today. Aleppo G Endocrinol Metab Clin North Am; 2020 Mar; 49(1):xv-xvi. PubMed ID: 31980126 [No Abstract] [Full Text] [Related]
15. Diabetes Technology in the Inpatient Setting for Management of Hyperglycemia. Davis GM; Galindo RJ; Migdal AL; Umpierrez GE Endocrinol Metab Clin North Am; 2020 Mar; 49(1):79-93. PubMed ID: 31980123 [TBL] [Abstract][Full Text] [Related]
16. Review of a commercially available hybrid closed-loop insulin-delivery system in the treatment of Type 1 diabetes. Stone JY; Haviland N; Bailey TS Ther Deliv; 2018 Feb; 9(2):77-87. PubMed ID: 29235423 [TBL] [Abstract][Full Text] [Related]
18. Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group. Fleming GA; Petrie JR; Bergenstal RM; Holl RW; Peters AL; Heinemann L Diabetes Care; 2020 Jan; 43(1):250-260. PubMed ID: 31806649 [TBL] [Abstract][Full Text] [Related]
19. The artificial pancreas: how close are we to closing the loop? Clarke WL; Kovatchev B Pediatr Endocrinol Rev; 2007 Jun; 4(4):314-6. PubMed ID: 17643078 [No Abstract] [Full Text] [Related]
20. Persistent heterogeneity in diabetes technology reimbursement for children with type 1 diabetes: The SWEET perspective. Sumnik Z; Szypowska A; Iotova V; Bratina N; Cherubini V; Forsander G; Jali S; Raposo JF; StipanĨic G; Vazeou A; Veeze H; Lange K; Pediatr Diabetes; 2019 Jun; 20(4):434-443. PubMed ID: 30773756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]